| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.1K | $723.8K | - | |
| VP | 68.8K | $185.0K | - | |
| CFO | 15.9K | $42.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2017 | Bosley Katrine | President And CEO | Sell | 16,666 | $20.02 | $333,609.99 | -0.6% | |
| Jun 2, 2017 | Nikolic Boris | Director | Buy | 35,000 | $14.07 | $492,527.00 | New | |
| Jun 2, 2017 | Cox Gerald Frank | Chief Medical Officer | Buy | 4,000 | $14.15 | $56,599.60 | New | |
| May 22, 2017 | Bitterman Kevin63 | Director | Sell | 1,000,000 | $17.00 | $17,000,000.00 | -26.3% | |
| Mar 15, 2017 | Glucksmann Alexandra | Chief Operating Officer | Sale+OE | 1,000 | $26.41 | $26,410.00 | -0.8% | |
| Feb 15, 2017 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 3,000 | $19.20 | $57,600.00 | -100% | |
| Feb 15, 2017 | Glucksmann Alexandra | Chief Operating Officer | Sale+OE | 6,000 | $20.58 | $123,484.40 | -2.5% | |
| Jan 11, 2017 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 15,000 | $19.20 | $288,000.00 | -100% | |
| Dec 7, 2016 | Polaris Venture Management Co. Vi, L.l.c. | 10% Owner | Sell | 75,000 | $15.82 | $1,186,500.00 | -1.9% | |
| Dec 7, 2016 | Bitterman Kevin63 | Director, 10% Owner | Sell | 75,000 | $15.82 | $1,186,500.00 | -1.9% |